QSAR modeling of bis-quinolinium and bis-isoquinolinium compounds as acetylcholine esterase inhibitors based on the Monte Carlo method—the implication for Myasthenia gravis treatment-Reference-Cited by-同舟云学术

QSAR modeling of bis-quinolinium and bis-isoquinolinium compounds as acetylcholine esterase inhibitors based on the Monte Carlo method—the implication for Myasthenia gravis treatment

Published:2016-09-15 Issue:12 Volume:25 Page:2989-2998
ISSN:1054-2523
Container-title:Medicinal Chemistry Research
language:en
Short-container-title:Med Chem Res

Author:

Sokolović Dušan,Aleksić Dragana,Milenković Vesko,Karaleić Sladjan,Mitić Dragana,Kocić Jadranka,Mekić Branimir,Veselinović Jovana B.,Veselinović Aleksandar M.

Funder

Ministry of Education and Science, the Republic of Serbia

Publisher

Springer Science and Business Media LLC

Subject

Organic Chemistry,General Pharmacology, Toxicology and Pharmaceutics

Link

http://link.springer.com/content/pdf/10.1007/s00044-016-1720-x.pdf

Reference36 articles.

1. Cherkasov A, Muratov EN, Fourches D, Varnek A, Baskin II, Cronin M, Dearden J, Gramatica P, Martin YC, Todeschini R, Consonni V, Kuz’Min VE, Cramer R, Benigni R, Yang C, Rathman J, Terfloth L, Gasteiger J, Richard A, Tropsha A (2014) QSAR modeling: where have you been? Where are you going to? J Med Chem 57:4977–5010

2. Conti-Fine BM, Milani M, Kaminski HJ (2006) Myasthenia gravis: past, present, and future. J Clin Invest 116:2843–2854

3. Cronin MTD, Schultz TW (2003) Pitfalls in QSAR. J Mol Struct-THEOCHEM 622:39–51